These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30565581)

  • 1. [Treatment of persistent opioid-induced constipation in patients with hematological malignancies: case report].
    Recenti Prog Med; 2018 Nov; 109(11):11e-14e. PubMed ID: 30565581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Opioid-induced constipation in oncologic patient: a clinical case treated with naloxegol].
    Gallo P
    Recenti Prog Med; 2019 Mar; 110(3):6e-9e. PubMed ID: 30968858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
    Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxegol for opioid-induced constipation in patients with noncancer pain.
    Chey WD; Webster L; Sostek M; Lappalainen J; Barker PN; Tack J
    N Engl J Med; 2014 Jun; 370(25):2387-96. PubMed ID: 24896818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM; Rhee D
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxegol to Treat Constipation in a Patient Taking Opioids for Cancer Pain: A Case Report.
    Gálvez R; Maire C; Tovar I; Vargas P
    A A Pract; 2018 Jul; 11(1):22-24. PubMed ID: 29634552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxegol for managing opioid-induced constipation.
    Shelton KN; Clements JN
    JAAPA; 2017 Sep; 30(9):51-53. PubMed ID: 28858018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxegol increases frequency of bowel movements and combats inadequate response to laxatives.
    Holzer P
    Evid Based Med; 2015 Feb; 20(1):5. PubMed ID: 25209526
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of naloxegol on anal sphincter function - Using a human experimental model of opioid-induced bowel dysfunction.
    Grønlund D; Poulsen JL; Krogh K; Brock C; Liao D; Gregersen H; Drewes AM; Olesen AE
    Eur J Pharm Sci; 2018 May; 117():187-192. PubMed ID: 29432808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.
    Webster L; Diva U; Tummala R; Sostek M
    Pain Pract; 2018 Apr; 18(4):505-514. PubMed ID: 28898536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation.
    Brenner DM; Hu Y; Datto C; Creanga D; Camilleri M
    Am J Gastroenterol; 2019 Jun; 114(6):954-963. PubMed ID: 31058652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxegol: a review of its use in patients with opioid-induced constipation.
    Garnock-Jones KP
    Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
    Cobo Dols M; Beato Zambrano C; Cabezón Gutiérrez L; Chicas Sett R; Blancas López-Barajas MI; García Navalón F; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Jiménez López AJ; Huerta González I; Sanz Yagüe A; Soler López B
    BMJ Support Palliat Care; 2021 Mar; 11(1):25-31. PubMed ID: 32376758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.
    Lawson R; King F; Marsh K; Altincatal A; Cimen A
    Adv Ther; 2016 Aug; 33(8):1331-46. PubMed ID: 27342744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxegol: treatment for opioid-induced constipation in chronic non-cancer pain.
    Leonard J; Baker DE
    Ann Pharmacother; 2015 Mar; 49(3):360-5. PubMed ID: 25471070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation.
    Lemaire A; Pointreau Y; Narciso B; Piloquet FX; Braniste V; Sabaté JM
    Support Care Cancer; 2021 Dec; 29(12):7577-7586. PubMed ID: 34120247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of adverse effects of opioid therapy].
    Wirz S
    Z Gastroenterol; 2017 Apr; 55(4):394-400. PubMed ID: 28363231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
    Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M
    Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.